Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Gardado en:
Autor Corporativo: | |
---|---|
Formato: | Livro |
Idioma: | Inglês |
Publicado: |
IntechOpen
2019
|
Assuntos: | |
Acceso en liña: | https://directory.doabooks.org/handle/20.500.12854/67013 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|